Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Colinz Laboratories Limited

Market Cap 11Cr 11.79L 10.19L 9L 9L 16.47L 16.72L 1.11Cr 43.21L 5.46Cr 44.26L 43.32L 19Cr P/E Ratio 2024
19.5x
P/E Ratio 2025 36.8x
Enterprise Value 6.3Cr 7L 6L 5L 5L 9L 9L 62.3L 24.29L 3.07Cr 24.88L 24.35L 11Cr EV / Sales 2024
0.43x
EV / Sales 2025 2.04x
Free-Float
31.44%
Yield 2024 *
-
Yield 2025 -
25/05 Padam Dugar, Annjana Dugar, Likhitta Dugar and Antariksh Dugar acquired 15.01% stake in Colinz Laboratories Limited. CI
29/04 Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
24/01 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
17/01 Hilsun Foods And Drugs Private Limited signed a letter of intent to acquire Factory Building, Factory Machinery, & Factory Land of Colinz Laboratories Limited for INR 40 million. CI
27/11 Colinz Laboratories Limited Appoints Falguni Kumawat as Company Secretary and Compliance Officer, with Effect from 1 December, 2025 CI
08/11 Colinz Laboratories Limited Announces of Demise Dr. Mani L.S., Founder Director, Company Secretary and Compliance Officer on 7 November 2025 CI
03/11 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
31/25/31 Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
21/25/21 Colinz Laboratories Limited Appoints Swapnil Jayesh Madiyar as Additional Director, Effective from May 16, 2025 CI
16/25/16 Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
04/25/04 Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
30/24/30 Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
01/24/01 Colinz Laboratories Limited Approves Board Appointments CI
1 day+2.88%
1 week-7.07%
Current month+2.26%
1 month+8.60%
3 months+25.79%
6 months+19.26%
Current year+1.96%
1 week 53.11
Extreme 53.11
64.89
1 month 42
Extreme 42
64.97
Current year 39.31
Extreme 39.31
87.91
1 year 36.11
Extreme 36.11
87.91
3 years 33.35
Extreme 33.35
88.7
5 years 14.55
Extreme 14.55
88.7
10 years 4.8
Extreme 4.8
88.7
Manager TitleAgeSince
Chief Executive Officer 73 -
Director of Finance/CFO - 20/05/2019
Compliance Officer - 01/12/2025
Director TitleAgeSince
Director/Board Member 73 26/11/1990
Director/Board Member 33 08/08/2024
Director/Board Member 76 08/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-7.07%-5.30%+48.26% 13.98L
+0.75%+1.55%+6.93%+83.72% 4.5TCr
-0.20%-3.59%+38.01%+87.26% 3.35TCr
+0.44%-0.66%-8.69%+43.35% 1.17TCr
-0.11%+1.85%+12.86%+117.57% 1.16TCr
+0.59%+0.78%+37.07%+126.43% 897.31Cr
+2.40%+0.42%+17.89%+42.70% 689.2Cr
-1.12%-0.56%+40.12%-18.60% 655.16Cr
+1.37%-0.31%+32.92%+241.77% 632.03Cr
+0.51%-2.46%-39.66%-6.34% 512.35Cr
Average +0.75%-1.38%+13.21%+76.61% 1.36TCr
Weighted average by Cap. +0.42%-0.96%+17.38%+83.78%

Financials

2024 2025
Net sales 7.03Cr 7L 6L 6L 6L 10.33L 10.49L 69.5L 27.1L 3.42Cr 27.76L 27.16L 12Cr 6.53Cr 7L 6L 5L 5L 10L 10L 64.54L 25.16L 3.18Cr 25.77L 25.23L 11Cr
Net income 48.67L 51.2T 44.23T 40.75T 38.15T 71.49T 72.6T 5L 2L 23.69L 2L 2L 82.02L 49.66L 52.25T 45.12T 41.58T 38.92T 72.94T 74.07T 5L 2L 24.17L 2L 2L 83.69L
Net Debt -6.43Cr -7L -6L -5L -5L -9L -10L -63.58L -24.79L -3.13Cr -25.39L -24.85L -11Cr -4.91Cr -5L -4L -4L -4L -7L -7L -48.54L -18.92L -2.39Cr -19.38L -18.97L -8.27Cr
Logo Colinz Laboratories Limited
Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.
Employees
65
Date Price Change Volume
12/26/12 54.68 +2.88% 3,172
11/26/11 53.15 -4.92% 3,129
10/26/10 55.90 -4.96% 1,941
09/26/09 58.82 -4.98% 2,863
08/26/08 61.90 +0.41% 1,886
  1. Stock Market
  2. Stocks
  3. 531210 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!